Search for Clinical Trial Results

Pancreatic Neuroendocrine Tumor - 25 Studies Found
Status | Study |
Recruiting |
Study Name: A Study of Famitinib in Patients With Advanced or Metastatic Gastroenteropancreatic Neuroendocrine Tumor Condition: Gastroenteropancreatic Neuroendocrine Tumor Date: 2013-11-19 Interventions: Drug: Famitinib Famitinib 25 mg p.o. qd |
Terminated |
Study Name: Diagnostic Accuracy of Gallium-68-DOTATATE PET/CT Compared to Indium-111-pentetreotide Scintigraphy (SPECT/CT) for Gastroenteropancreatic Neuroendocrine Tumors Condition: Gastroenteropancreatic Neuroendocrine Tumors Date: 2014-02-26 Interventions:
|
Not yet recruiting |
Study Name: Study of Pembrolizumab With Lanreotide Depot for Gastroenteropancreatic Neuroendocrine Tumors Condition: Gastroenteropancreatic Neuroendocrine Tumors Date: 2017-02-01 Interventions:
|
Recruiting |
Study Name: Lanreotide and Octreotide Long Acting Release (LAR) for Patients With Advanced Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) Condition: Gastroenteropancreatic Neuroendocrine Tumor Date: 2016-12-30 |
Completed |
Study Name: TEP With 68-DOTANOC in Gastroenteropancreatic Neuroendocrine Tumors Condition: Patients With Gastroenteropancreatic Neuroendocrine Tumors Date: 2012-11-13 Interventions: Drug: 68-Ga-DOTANOC |
Completed |
Study Name: Quality of Life, Treatment Experience and Cost of Treatment With Somatostatin Analogues in Patients With Gastroenteropancreatic Neuroendocrine Tumours Condition: Gastroenteropancreatic Neuroendocrine Tumours Date: 2016-05-27 |
Not yet recruiting |
Study Name: [68 Ga]-DOTANOC PET/CT in GEP-NETs Condition: Gastroenteropancreatic Neuroendocrine Tumors Date: 2015-11-09 Interventions: Drug: [68Ga]-DOTANOC PET/CT |
Recruiting |
Study Name: Community-based Neuroendocrine Tumor (NET) Research Study Condition: Gastroenteropancreatic Neuroendocrine Tumors Date: 2016-04-01 |
Withdrawn |
Study Name: Pasireotide Treatment for Neuroendocrine Tumor Condition: Gastro-enteropancreatic Neuroendocrine Tumor Date: 2016-05-16 Interventions:
|
Recruiting |
Study Name: Study For Evaluating The Value Of A Multi Biomarker Approach In Metastatic GEP NETs Condition: Gastroenteropancreatic Neuroendocrine Tumors Date: 2015-12-11 Interventions: Other: This is a non-interventional study. Patients will be treated with any intervention deemed appropriate by the patient's physician. |